Ian M Anderson

Summary

Affiliation: University of Manchester
Country: UK

Publications

  1. ncbi Efficacy, safety and tolerability of quetiapine augmentation in treatment resistant depression: an open-label, pilot study
    I M Anderson
    Manchester Mental Health and Social Care Trust University of Manchester, United Kingdom
    J Affect Disord 117:116-9. 2009
  2. ncbi Assessing human 5-HT function in vivo with pharmacoMRI
    I M Anderson
    Neuroscience and Psychiatry Unit, The University of Manchester, Room G907, Stopford Building, Oxford Road, Manchester M13 9PT, United Kingdom
    Neuropharmacology 55:1029-37. 2008
  3. ncbi Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines
    I M Anderson
    Senior Lecturer and Honorary Consultant Psychiatrist, Neuroscience and Psychiatry Unit, University of Manchester, UK
    J Psychopharmacol 22:343-96. 2008
  4. ncbi Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study
    Ian M Anderson
    Neuroscience and Psychiatry Unit, The University of Manchester, Stopford Building, Oxford Road, Manchester, UK
    Neuroreport 18:1351-5. 2007
  5. ncbi Adjunctive fast repetitive transcranial magnetic stimulation in depression
    Ian M Anderson
    Neuroscience and Psychiatry Unit, University of Manchester, Manchester, UK
    Br J Psychiatry 190:533-4. 2007
  6. ncbi The effect of acute citalopram on face emotion processing in remitted depression: a pharmacoMRI study
    Ian M Anderson
    Neuroscience and Psychiatry Unit, School of Community Based Medicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, M13 9PT, UK
    Eur Neuropsychopharmacol 21:140-8. 2011
  7. ncbi Making decisions in the absence of high quality clinical evidence: we need to bring some science into the judgement
    Ian Anderson
    Neuroscience and Psychiatry Unit, University of Manchester, Manchester, UK
    J Psychopharmacol 19:133. 2005
  8. ncbi State-dependent alteration in face emotion recognition in depression
    Ian M Anderson
    Neuroscience and Psychiatry Unit, School of Community Based Medicine, Stopford Building, Oxford Road, Manchester M13 9PT, UK
    Br J Psychiatry 198:302-8. 2011
  9. ncbi Prescribing antidepressants for depression: time to be dimensional and inclusive
    Ian M Anderson
    Neuroscience and Psychiatry Unit, School of Community Based Medicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK
    Br J Gen Pract 61:50-2. 2011
  10. ncbi The HTR1A and HTR1B receptor genes influence stress-related information processing
    Krisztina Mekli
    Neuroscience and Psychiatry Unit, School of Community Based Medicine, Faculty of Medical and Human Sciences, The University of Manchester, UK
    Eur Neuropsychopharmacol 21:129-39. 2011

Collaborators

Detail Information

Publications30

  1. ncbi Efficacy, safety and tolerability of quetiapine augmentation in treatment resistant depression: an open-label, pilot study
    I M Anderson
    Manchester Mental Health and Social Care Trust University of Manchester, United Kingdom
    J Affect Disord 117:116-9. 2009
    ..Atypical antipsychotics may have efficacy as augmentation therapy in treatment resistant depression (TRD) but evidence is limited...
  2. ncbi Assessing human 5-HT function in vivo with pharmacoMRI
    I M Anderson
    Neuroscience and Psychiatry Unit, The University of Manchester, Room G907, Stopford Building, Oxford Road, Manchester M13 9PT, United Kingdom
    Neuropharmacology 55:1029-37. 2008
    ..If this is successful then phMRI will provide a genuinely exciting opportunity for the rapid development of better treatments for psychiatric conditions...
  3. ncbi Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines
    I M Anderson
    Senior Lecturer and Honorary Consultant Psychiatrist, Neuroscience and Psychiatry Unit, University of Manchester, UK
    J Psychopharmacol 22:343-96. 2008
    ....
  4. ncbi Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study
    Ian M Anderson
    Neuroscience and Psychiatry Unit, The University of Manchester, Stopford Building, Oxford Road, Manchester, UK
    Neuroreport 18:1351-5. 2007
    ..No citalopram modulation of BOLD responses to angry faces were found. These results suggest that serotonin modulates low-level amygdala activation to aversive stimuli...
  5. ncbi Adjunctive fast repetitive transcranial magnetic stimulation in depression
    Ian M Anderson
    Neuroscience and Psychiatry Unit, University of Manchester, Manchester, UK
    Br J Psychiatry 190:533-4. 2007
    ..77% responding, P<0.05), with improvement maintained to 12 weeks. This therapy could be a useful addition to available treatments but further research is needed to determine the optimum treatment parameters...
  6. ncbi The effect of acute citalopram on face emotion processing in remitted depression: a pharmacoMRI study
    Ian M Anderson
    Neuroscience and Psychiatry Unit, School of Community Based Medicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, M13 9PT, UK
    Eur Neuropsychopharmacol 21:140-8. 2011
    ....
  7. ncbi Making decisions in the absence of high quality clinical evidence: we need to bring some science into the judgement
    Ian Anderson
    Neuroscience and Psychiatry Unit, University of Manchester, Manchester, UK
    J Psychopharmacol 19:133. 2005
  8. ncbi State-dependent alteration in face emotion recognition in depression
    Ian M Anderson
    Neuroscience and Psychiatry Unit, School of Community Based Medicine, Stopford Building, Oxford Road, Manchester M13 9PT, UK
    Br J Psychiatry 198:302-8. 2011
    ..Negative biases in emotional processing are well recognised in people who are currently depressed but are less well described in those with a history of depression, where such biases may contribute to vulnerability to relapse...
  9. ncbi Prescribing antidepressants for depression: time to be dimensional and inclusive
    Ian M Anderson
    Neuroscience and Psychiatry Unit, School of Community Based Medicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK
    Br J Gen Pract 61:50-2. 2011
    ..This involves a personalised assessment of the likely benefits and risks of both psychological and drug approaches when recommending treatment for someone with depression...
  10. ncbi The HTR1A and HTR1B receptor genes influence stress-related information processing
    Krisztina Mekli
    Neuroscience and Psychiatry Unit, School of Community Based Medicine, Faculty of Medical and Human Sciences, The University of Manchester, UK
    Eur Neuropsychopharmacol 21:129-39. 2011
    ....
  11. ncbi The CREB1-BDNF-NTRK2 pathway in depression: multiple gene-cognition-environment interactions
    Gabriella Juhasz
    Neuroscience and Psychiatry Unit, University of Manchester, Manchester, United Kingdom
    Biol Psychiatry 69:762-71. 2011
    ....
  12. ncbi Reversed frontotemporal connectivity during emotional face processing in remitted depression
    Nia Goulden
    Neuroscience and Psychiatry Unit, University of Manchester and Manchester Academic Health Sciences Centre, Manchester, United Kingdom
    Biol Psychiatry 72:604-11. 2012
    ..This suggests the problem might lie in the integrated functioning of emotion processing circuits...
  13. ncbi Variations in the cannabinoid receptor 1 gene predispose to migraine
    Gabriella Juhasz
    Neuroscience and Psychiatry Unit, University of Manchester, Manchester, UK
    Neurosci Lett 461:116-20. 2009
    ..However, further studies are needed to elucidate the role of CNR1 and the cannabinoid system in migraine...
  14. ncbi Increased amygdala responses to sad but not fearful faces in major depression: relation to mood state and pharmacological treatment
    Danilo Arnone
    Neuroscience and Psychiatry Unit and Department of Imaging Science and Biomedical Engineering, University of Manchester, Manchester, United Kingdom
    Am J Psychiatry 169:841-50. 2012
    ....
  15. ncbi Risk-taking behavior in a gambling task associated with variations in the tryptophan hydroxylase 2 gene: relevance to psychiatric disorders
    Gabriella Juhasz
    Neuroscience and Psychiatry Unit, School of Community Based Medicine, Faculty of Medical and Human Sciences, The University of Manchester, Manchester, UK
    Neuropsychopharmacology 35:1109-19. 2010
    ..In conclusion, our study demonstrates the role of the TPH2 gene and the serotonin system in risk taking and suggests that TPH2 gene may contribute to the expression of psychiatric phenotypes through altered decision making...
  16. ncbi Neural correlates of choice behavior related to impulsivity and venturesomeness
    Neal S Hinvest
    Neuroscience and Psychiatry Unit, School of Community Based Medicine, University of Manchester, Oxford Road, Manchester M13 9PT, United Kingdom
    Neuropsychologia 49:2311-20. 2011
    ..They also provide targets for the further investigation into the pathophysiology of addiction and impulse-control disorders...
  17. ncbi Reduced medial prefrontal responses to social interaction images in remitted depression
    Rebecca Elliott
    Neuroscience and Psychiatry Unit, University of Manchester, Manchester, England
    Arch Gen Psychiatry 69:37-45. 2012
    ..Stimuli with social context represent a distinct class of emotional stimuli, which in healthy volunteers are associated with specific neural substrates but have not previously been studied relative to vulnerability to depression...
  18. ncbi Serotonergic modulation of neuronal responses to behavioural inhibition and reinforcing stimuli: an fMRI study in healthy volunteers
    Birgit Völlm
    Neuroscience and Psychiatry Unit, University of Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, UK
    Eur J Neurosci 23:552-60. 2006
    ..Combining drug challenge with fMRI (pharmacoMRI; pMRI) is a promising tool for investigating these processes in healthy as well as patient groups...
  19. ncbi Mirtazapine antagonises the subjective, hormonal and neuronal effects of m-chlorophenylpiperazine (mCPP) infusion: a pharmacological-challenge fMRI (phMRI) study
    Shane McKie
    Neuroscience and Psychiatry Unit, University of Manchester, Manchester, UK
    Neuroimage 58:497-507. 2011
    ..The results suggest that mCPP-challenge phMRI produces reliable patterns of response that are mediated by 5-HT(2C) receptors; these responses may therefore be useful in-vivo measures of 5-HT(2C) function in psychiatric disorders...
  20. ncbi CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms
    Gabriella Juhasz
    Neuroscience and Psychiatry Unit, School of Community Based Medicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK
    Neuropsychopharmacology 34:2019-27. 2009
    ..This study also suggests that the CNR1 gene influences vulnerability to recent psychosocial adversity to produce current symptoms of depression...
  21. ncbi Diminished neural and cognitive responses to facial expressions of disgust in patients with psoriasis: a functional magnetic resonance imaging study
    C Elise Kleyn
    Dermatological Sciences, The University of Manchester, Manchester, UK
    J Invest Dermatol 129:2613-9. 2009
    ..We hypothesize that patients with psoriasis, in this case male patients, develop a coping mechanism to protect them from stressful emotional responses by blocking the processing of disgusted facial expressions...
  22. ncbi Affective cognition and its disruption in mood disorders
    Rebecca Elliott
    Neuroscience and Psychiatry Unit, School of Community Based Medicine, University of Manchester, Manchester, UK
    Neuropsychopharmacology 36:153-82. 2011
    ..The final section presents an overview of this literature and considers implications for understanding the pathophysiology of mood disorder as well as developing and evaluating new treatment strategies...
  23. ncbi Detection of the acute effects of hydrocortisone in the hippocampus using pharmacological fMRI
    Catherine S Symonds
    Neuroscience and Psychiatry Unit, G 907 Stopford Building, The University of Manchester and Manchester Academic Health Sciences Centre, Oxford Road, Manchester M13 9PT, United Kingdom Electronic address
    Eur Neuropsychopharmacol 22:867-74. 2012
    ..Hydrocortisone infusion phMRI may be a useful tool to investigate hippocampal corticosteroid receptor function in depression...
  24. ncbi The relationship between serotonergic function and the Psychopathy Checklist: Screening Version
    Mairead C Dolan
    Adult Forensic Mental Health Services, Mental Health Services of Salford and Department of Psychiatry, University of Manchester, Manchester, UK
    J Psychopharmacol 17:216-22. 2003
    ..In line with previous research findings, impulsive-antisocial conduct shows an inverse relationship with 5-HT function. Arrogant/deceitful traits correlate positively with 5-HT function and may be an adaptive component of psychopathy...
  25. ncbi The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study
    Cristina M Del-Ben
    , , , Brazil
    Neuropsychopharmacology 30:1724-34. 2005
    ..The technique of combining drug challenge with fMRI (pharmacoMRI) has promise for investigating human psychiatric disorders...
  26. ncbi Changes in pharmacological treatment for bipolar disorder over time in Manchester: a comparison with Lloyd et al. (2003)
    Ian M Anderson
    J Psychopharmacol 18:441-4. 2004
  27. ncbi Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
    David S Baldwin
    Division of Clinical Neurosciences, University of Southampton, Southampton, UK
    J Psychopharmacol 19:567-96. 2005
    ..The guidelines cover the diagnosis of anxiety disorders and key steps in clinical management, including acute treatment, relapse prevention and approaches for patients who do not respond to first-line treatments...
  28. ncbi The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study
    Aung Tint
    Bolton, Trafford and Salford Mental Health NHS Trust, Kenyon House, Prestwich Hospital, Bury New Road, Manchester M25 3BL, UK
    J Psychopharmacol 22:330-2. 2008
    ..Antidepressant discontinuation in depressed patients can be associated with worsening depression and increased suicidality...
  29. ncbi Clinical trials of antidepressant medications are producing meaningless results
    Gordon Parker
    School of Psychiatry, University of New South Wales, Australia
    Br J Psychiatry 183:102-4. 2003
  30. ncbi Effect of acute tryptophan depletion on the response to controllable and uncontrollable noise stress
    Rebecca A Richell
    Psychiatry Group, Medical Research Council Clinical Sciences Centre, Imperial College, London
    Biol Psychiatry 57:295-300. 2005
    ..Acute tryptophan depletion (ATD) is a technique that produces a decrease in central 5-HT levels in vivo. This study investigated the role of 5-HT in the behavioral response to a C/UC stress paradigm with ATD...